The EU market is expected to be the World´s largest cannabis market – larger than the whole US market. This is due to the heavy demand for medical cannabis as an alternative to conventional treatment. This market is expected to be 350 million people by 2021. Medical marijuana is the extract of the marijuana plant for treating symptoms of illness, pain treatment and other conditions. It contains non-intoxicating CBD (cannabidiol) and intoxicating THC (tetrahydrocannabinol) – both with properties that can be used for medical treatment and represent an alternative to conventional treatment.

Orenda is one of the largest operations in EU for production with planned preliminary agreement of growth sites of 1.6 mio ft2 and an optional second site of 3.2 mio ft2 to scale for market demand.

Orenda will offer an array of CBD and THC products from own certified GMP facilities. They aim to provide patients, customers, and partners with the highest quality products and as a leader in the global cannabis industry, they strive to make a positive difference in the local communities where they operate around the world. Utilizing cutting-edge agronomy know-how and a wide-reaching proprietary distribution network, Orenda is well-positioned to support the large and growing demand base in its identified markets.